“February 5, 2001 Intelligence: Late Breaking Lab News”

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

This time the Clinical Laboratory Management Association (CLMA) looked in its own backyard to find a Executive Director. On Monday, February 12, Robert Neri will begin his responsibilities at CLMA. Not only does Neri have a long career in laboratory management, but he lives in the Philadelphia area, near CLMA’s offices in Malvern, Pennsylvania. CLMA’s immediate past two executive directors came from the association management industry.

NEW PRESIDENT AT IMPATH , INC.

At least one anatomic pathology company recognizes the important contribution that sales and marketing makes to sustained growth and profitability. IMPATH, Inc. recently promoted Richard P. Adelson to President and COO. Adelson started with IMPATH in 1992 as regional sales manager and supervised the sales and marketing effort throughout IMPATH’s formative years. Impath’s former President, Anu Saad, M.D. assumed duties as Chairman of the Board and CEO.

GENERAL MOTORS USING MEDSCAPE TO CONTROL COST OF HEALTHCARE

Here’s an early warning sign for clinical laboratories. General Motors Corp. signed a three-year pact with MedicaLogic/Medscape, Inc. for the purpose of reducing healthcare costs and attacking medical errors. GM will use Medscape’s products for electronic prescribing and medical records. The companies will target 6,000 physicians in cities where GM has a large number of employees and retirees. Some 1.2 million people get their health coverage through GM, so this is a sizable undertaking.

MORE ON: GENERAL MOTORS

GM spent almost $4 billion on healthcare in 2000. Prescriptions account for $1 billion of this amount, which is why GM made this area a priority. It hopes electronic ordering systems will help physicians prescribe generics or lower-cost drugs and reduce medical errors associated with harmful drug interactions, illegibly-written prescriptions, and the like. THE DARK REPORT believes that GM’s migration to an electronic patient record will form the foundation for a next-generation cost cutting and quality-boosting effort which would logically involve clinical lab test data. Further, GM’s efforts, if successful, will be copied by other corporations looking to control the cost of their own health programs.

QUEST, AETNA, AND HCA TO TAP MARKETS FOR $BILLIONS

Healthcare must be riding high on Wall Street, despite recent financial doldrums. Within a week of each other, Quest Diagnostics Incorporated, HCA-The Healthcare Co., and Aetna Inc. announced plans to raise money. Quest Diagnostics filed a universal shelf registration for $750 million to issue various types of securities, including debt preferred stock, and common stock. HCA is selling $500 million of high-yield bonds, and Aetna will sell $2 billion in debt securities.

Comments

Leave a Reply